BSECorp. Action6d ago · 6 Aug 2026, 06:00 pm

Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday ....

Syncom Formulations India Ltd-$ · 524470

✦ AI SummaryResults

Syncom Formulations India Ltd has scheduled its 2/2026-27 Board Meeting on August 11th to consider dividend, financial results, and other matters.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Syncom Formulations India Ltd-$ - 524470 - Corporate Action-Board to consider Dividend

Attachments (1)

📄

1501b13b-3548-44ae-a043-fe57dfb4b8af.pdf

pdf

Download →
View document text
SYNCOM/SE/2026-27 06th August, 2026 Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Sandra Kurla Complex, Sandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF Sub: Corporate Announcement u/r 29(1)(a) of SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 regarding intimation of holding the 2/2026-27 Board Meeting scheduled to be held on Tuesday, 11th day of August, 2026. Dear Sir/Ma’am, Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 as amended from time to time, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 11th day of August, 2026 at 4:00 P.M. (IST) at the Corporate Office situated at 207, Saket Nagar, Near Saket Club Indore (M.P.) 452018 to consider and approve the following businesses along with other routine businesses: a) To consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter ended 30th June, 2026; b) To take on record the Standalone and Consolidated Limited Review Report by Auditors for the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2026. c) To consider and recommend the Final Dividend, on equity shares of the Company for the Financial Year ended 31st March, 2026, if any; d) To consider and approve other matter. We are also in process of filing the aforesaid Intimation u/r 29(1)(a) in the XBRL format within the stipulated time and same shall be hosted on the Website of the Company. Further, we have already updated the details of trading window closure end date in the system of designated depository in terms of SEBI circular No. SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated 19th July, 2023. You are requested to please take on record our above said information for your reference and disseminate on the website of the BSE/NSE. Thanking You, Yours Faithfully, For, SYNCOM FORMULATIONS (INDIA) LIMITED VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER